CD68 and neoplasm: No expression on CD4/CD8 T cells in pre-treatment tumor tissues, but detected on 4% of CD4 T cells and 7% on CD8 T cells after ipilimumab therapy; the expression on CD68+ macrophages increased ~4-fold (from 7% to 31%)